The risk of ovarian cancer in Lynch syndrome is mainly associated with MLH1, MSH2 and MSH6 pathogenic variants, and the MSH2 pathogenic variant showed the highest risk among the four gene variants, with a cumulative incidence ranging from 10.8 to 17.4% by age 75 [20]. Here, MSH2 is linked to ovarian cancer.